What is TriSalus Life Sciences, Inc.'s R&D?

TriSalus Life Sciences, Inc. (TLSI) reported R&D of $3.22M in Q1 2026.

How has TriSalus Life Sciences, Inc.'s R&D changed year-over-year?

TriSalus Life Sciences, Inc.'s R&D increased by 6.5% year-over-year, from $3.02M to $3.22M.

What is the long-term trend for TriSalus Life Sciences, Inc.'s R&D?

Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s R&D has grown at a -29.8% compound annual growth rate (CAGR), from $29.8M to $14.69M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

TriSalus Life Sciences, Inc. TLSI R&D

R&D at other companies

AngioDynamicsANGO

$7.08M+2.5%

Delcath SystemsDCTH

$9.82M+96.2%

Tactile Systems TechnologyTCMD

$2.78M+59.4%

LQD

Liquidia CorporationLQDA

$12.57M+80.5%

United TherapeuticsUTHR

$138.2M-7.2%

Cullinan Therapeutics, Inc.CGEM

$42.12M+1.6%

Other financials

Income statement

See full

Revenue$8.9M-2.9%

Gross profit$7.7M0.0%

Operating income-$8.4M-14.8%

Net income$1.5M+115%

EPS (diluted)$0.03+108%

Balance sheet

See full

Cash & equivalents$56.6M+324%

Total debt$33.1M+4.4%

Total equity$12.8M+137%

Total assets$71.0M+148%

Cash flow

See full

Operating cash flow-$6.5M-44.0%

CapEx$141.0K-81.3%

Free cash flow-$6.6M-26.0%

Valuation

See full

Market cap$279.45M+49.6%

Enterprise value$255.97M+33.6%

P/S6.2×+1.0×

Profitability

See full

Gross margin85.1%-0.5pp

Operating margin-62.4%-16.8pp

Net margin-60.9%-13.4pp

FCF margin-45.2%-16.8pp

Returns & leverage

See full

Return on equity253.3%—

Debt / equity2.6×—

Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s R&D?: TriSalus Life Sciences, Inc. (TLSI) reported R&D of $3.22M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s R&D changed year-over-year?: TriSalus Life Sciences, Inc.'s R&D increased by 6.5% year-over-year, from $3.02M to $3.22M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s R&D?: Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s R&D has grown at a -29.8% compound annual growth rate (CAGR), from $29.8M to $14.69M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.